Latest

Politics John Wilkerson

STAT Plus: Medicare scrambles to keep prescription drug plan premiums stable ahead of elections

Health Lev Facher

Politics is holding back the best tool for treating meth addiction

First Opinion Jeffrey S. Flier

Diversity statements should not be required for federal STEMM grant funding

First Opinion Mike Zuendel

Phasing out the ‘D-word’

First Opinion Jo Morrison and Eric Moore

Performance-enhancing drugs or placebos? The myth at the heart of anti-doping

Letters to the editor Patrick Skerrett

Letters on Sonya Massey’s death, vaccine injuries, and much more

Health tech Katie Palmer

Weight loss drugs without a prescription? Study warns it’s a ‘very risky business’

First Opinion John P. Moore

The coronavirus lab leak hypothesis is damaging science

Health tech Matthew Herper

STAT Plus: 23andMe board rejects co-founder Anne Wojcicki’s offer to take company private

The Readout Elaine Chen

Moderna is still in a Covid hangover

First Opinion Alison Bateman-House and Holly Fernandez Lynch

Trump gave patients a ‘right to try.’ It hasn’t helped them

Hospitals Tara Bannow

STAT Plus: UnitedHealth and HCA clash over hospital chain’s rates in ‘battle of the giants’

First Opinion Amy West

ACL tears in women: Too many injuries and too little research

In the Lab Brittany Trang

What we do and don’t know about the shortage of blood culture bottles

First Opinion Gebra Cuyun Carter and Caitlin Kubler

Address liquid biopsy disparities today to ensure equity in outcomes tomorrow

Biotech Andrew Joseph

STAT Plus: FDA approves innovative T cell immunotherapy for rare soft-tissue cancer

Business Bob Herman

STAT Plus: Private equity firms to acquire health care billing and payments firm R1 in $8.9 billion deal

Morning Rounds Theresa Gaffney

Morning Rounds: Inside the making of the first malaria vaccine

Adam's Biotech Scorecard Adam Feuerstein

STAT Plus: On Andrew Left and the government’s fraud case

First Opinion Jason Resendez

Make caregiving a defining issue of the 2024 election

Biotech Andrew Joseph

STAT Plus: Jim Wilson, gene therapy pioneer, departs Penn to set up new companies

The Readout Elaine Chen

STAT Plus: venBio raises $528 million for its fifth fund

Biotech Adam Feuerstein

STAT Plus: With new data, Regenxbio advances plan for Duchenne gene therapy

Biotech Elaine Chen

STAT Plus: Eli Lilly’s obesity drug Zepbound shows benefits in heart failure patients

Special Report Andrew Joseph

4 takeaways from STAT’s story on the development of malaria vaccines

First Opinion Darrell Rigel

Rising rates of skin cancer: The cost of FDA’s inaction on novel sunscreen products

Special Report Andrew Joseph

Behind the malaria vaccines: A 40-year quest against one of humanity’s biggest killers

First Opinion Juliana M. Reed

PBMs aren’t opening access to lower-cost biosimilars. Reform is needed now

In the Lab Angus Chen

STAT Plus: With Biden’s departure in sight, advocates seek to preserve gains of Cancer Moonshot